Variable | Overall | Age ≥ 65 years | ||
---|---|---|---|---|
NHANES | Projected national estimate | NHANES | Projected national estimate | |
N = 2915 | N = 1466 | |||
Mean (SE) age, years | 63.9 (0.2) | 61.4 (0.4) | 73.4 (0.1) | 73.1 (0.1) |
Age ≥ 65 years, % (n) | 50.3 (1466) | 40.3 (N/A) | 100 (1466) | 100 (N/A) |
Sex, % male (n) | 52.0 (1517) | 50.8 (N/A) | 51.8 (760) | 47.1 (N/A) |
Mean (SE) diabetes duration, years | 10.7 (0.2) | 9.7 (0.2) | 13.2 (0.3) | 12.9 (0.3) |
Mean (SE) eGFR (CKD-EPI), ml/min/1.73 m2 | 78.2 (0.5) | 80.5 (0.5) | 65.3 (0.6) | 64.2 (0.8) |
Mean (SE) eGFR (MDRD), ml/min/1.73 m2 | 78.5 (0.5) | 79.1 (0.6) | 66.7 (0.6) | 64.8 (0.8) |
Mean (SE) UAE, mg/g | 109.7 (1.3) | 109.1 (1.4) | 103.4 (1.6) | 99.1 (1.8) |
Race/ethnicity | ||||
Mexican American, % (n) | 21.9 (638) | 8.1 (N/A) | 18.4 (269) | 5.0 (N/Aa) |
Other Hispanic, % (n) | 7.9 (231) | 5.9 (N/A) | 6.0 (88) | 3.4 (N/Aa) |
Non-Hispanic white, % (n) | 37.9 (1105) | 62.6 (N/A) | 47.0 (689) | 72.6 (N/Aa) |
Non-Hispanic black, % (n) | 26.5 (773) | 15.9 (N/A) | 23.1 (338) | 12.4 (N/Aa) |
Other, including multiracial, % (n) | 5.8 (168) | 7.4 (N/A) | 5.6 (82) | 6.5 (N/Aa) |
Comorbidities (self-reported) | ||||
Hypertension, % (n)a | 74.0 (2157) | 71.9 (N/A) | 80.3 (1177) | 80.9 (N/Aa) |
Retinopathy, % (n) | 22.1 (645) | 20.9 (N/A) | 23.1 (339) | 22.2 (N/Aa) |
Coronary heart disease, % (n) | 12.0 (351) | 12.5 (N/A) | 16.6 (243) | 19.9 (N/Aa) |
Myocardial infarction, % (n) | 12.7 (371) | 12.0 (N/A) | 16.5 (241) | 18.2 (N/Aa) |
Congestive heart failure, % (n) | 11.2 (326) | 10.6 (N/A) | 15.5 (227) | 16.9 (N/Aa) |
Angina, % (n) | 9.0 (261) | 9.5 (N/A) | 11.4 (167) | 13.9 (N/Aa) |
Stroke, % (n) | 10.1 (293) | 9.1 (N/A) | 13.6 (200) | 14.4 (N/Aa) |